文献速递妇科生殖医学

卵巢子宫内膜异位囊肿治疗中囊肿剔除术与「一步法」激光汽化术后卵巢储备功能的评估:一项小型随机临床试验

Assessment of ovarian reserve after cystectomy versus 'one-step' laser vaporization in the treatment of ovarian endometrioma: a small randomized clinical trial.
PubMed 文献 · Hum Reprod · 2018-01-01

一项多中心随机临床试验纳入60例有症状且直径大于3 cm的卵巢子宫内膜异位囊肿患者,1:1随机分为腹腔镜囊肿剔除术组与CO2光纤激光汽化术组。术后3个月,激光汽化组手术侧卵巢窦卵泡计数较囊肿剔除组显著升高(P=0.016);囊肿剔除组血清抗苗勒管激素显著下降(P=0.012),激光汽化组无显著下降。作者认为CO2激光技术可能对邻近健康卵巢组织损伤最小,但研究样本量有限、随访较短,属初步临床试验。

要点

  • 术后3个月激光汽化组手术侧卵巢窦卵泡计数较囊肿剔除组显著升高(P=0.016)。
  • 囊肿剔除组血清抗苗勒管激素术后3个月显著下降(P=0.012),激光汽化组无显著下降。
  • 作者认为CO2激光技术可能对邻近健康卵巢组织损伤最小,但属初步临床试验。

核心结论

  • 同时评估窦卵泡计数与血清抗苗勒管激素作为卵巢储备指标,结果提示CO2技术可能作为子宫内膜异位囊肿的替代治疗,对邻近健康卵巢组织损伤最小。
  • 作者认为本研究应视为初步临床试验,旨在促进未来更大规模试验来探讨这一临床相关问题。

研究设计与样本

  • 多中心随机临床试验,2017年7月至2018年2月期间纳入60例患者,计算机随机按1:1分配至第1组(腹腔镜囊肿剔除术)或第2组(CO2激光汽化术)。
  • 纳入因有症状(不孕和/或盆腔痛)且直径大于3 cm的子宫内膜异位囊肿接受手术的患者;排除年龄≥40岁、深部浸润型子宫内膜异位症/子宫腺肌病、既往卵巢手术或子宫切除术者。
  • 主要终点为两组组内手术前后窦卵泡计数变化(ΔAFC)的比较;次要终点为两组组内手术前后血清抗苗勒管激素变化(ΔAMH)的比较。
  • 患者术前及术后1个月、3个月随访时行盆腔超声检查测定窦卵泡计数并采血测定抗苗勒管激素水平。

主要发现

  • 手术侧卵巢窦卵泡计数:第1组(囊肿剔除术)从基线4.1 ± 2.2(均值 ± 标准差)升至3个月随访6.3 ± 3.5(95%CI:0.9-4);第2组(激光汽化术)从基线3.6 ± 1.9升至3个月随访8.6 ± 4.2(95%CI:2.8-7.1);第2组较第1组显著升高(P=0.016)。
  • 血清抗苗勒管激素:第1组从基线2.6 ± 1.4 ng/mL降至3个月随访1.8 ± 0.8 ng/mL(95%CI:-1.3至-0.2;P=0.012),较第2组显著下降;第2组从基线2.3 ± 1.1 ng/mL至3个月随访1.9 ± 0.9 ng/mL(95%CI:-1至-0.2;P=0.09),无显著下降。

局限性

  • 窦卵泡计数在评估合并子宫内膜异位囊肿卵巢的卵巢储备方面准确性低。
  • 研究样本量有限。
  • 随访时间相对较短,无法得出确定性结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does CO2 laser vaporization offer better results in treating endometrioma in terms of ovarian reserve preservation compared to traditional cystectomy? SUMMARY ANSWER: Assessing both antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) levels as measures of ovarian reserve, the results suggest that CO2 technology may be an alternative treatment for endometrioma, causing minimal damage to adjacent healthy ovarian tissue. WHAT IS KNOWN ALREADY: Excisional surgery has been questioned as an ideal surgical approach for endometriomas because it is associated with potential reduction of ovarian reserve. Recently, vaporization with CO2 laser in-line-of-sight, according to the 'three-step procedure', has been proposed as the best method to preserve ovarian function. However, no randomized controlled trials have been conducted to compare cystectomy and 'one-step' CO2 fiber laser vaporization (without GnRH agonist therapy) with respect to the ovarian reserve. STUDY DESIGN, SIZE, DURATION: A multicentre randomized clinical trial including 60 patients was performed between July 2017 and February 2018. Computerized randomization was conducted to allocate them in a proportion of 1:1 either to Group 1 (laparoscopic stripping: cystectomy) or Group 2 (CO2 laser vaporization). Patients in Group 1 underwent a standardized laparoscopic stripping technique; patients in Group 2 underwent drainage of the cyst content, biopsy and vaporization of the internal wall with a CO2 fiber laser. Patients underwent pelvic ultrasound examination to determine the AFC and blood sampling to determine AMH levels before surgery and at 1- and 3-month follow-up. PARTICIPANTS/MATERIALS, SETTING, METHODS: Patients undergoing surgery for symptomatic endometriomas (infertility and/or pelvic pain) larger than 3 cm were randomized in two groups according to the surgical technique. Patients aged ≥40 years, or with deep infiltrating endometriosis/adenomyosis, or previously submitted to surgical procedures on the ovaries or to hysterectomy were excluded from the study. The primary endpoint was the comparison of intra-group AFC changes before and after surgery (ΔAFC) between the two groups (ΔAFC Group 1 versus ΔAFC Group 2). The secondary endpoint was the modification of serum AMH before and after surgery (ΔAMH) between the two groups (ΔAMH Group 1 versus ΔAMH Group 2). MAIN RESULTS AND THE ROLE OF CHANCE: The AFC of the operated ovary was significantly increased in Group 2 (laser vaporization) compared with Group 1 (cystectomy) after surgery (Group 1: from 4.1 ± 2.2 [mean ± SD] at baseline to 6.3 ± 3.5 at 3-month follow-up; 95% CI: 0.9-4; Group 2: from 3.6 ± 1.9 at baseline to 8.6 ± 4.2 at 3-month follow-up; 95% CI: 2.8-7.1; P = 0.016); serum AMH levels were significantly reduced at 3 months in Group 1 (from 2.6 ± 1.4 ng/mL at baseline to 1.8 ± 0.8 ng/mL at 3-month follow-up; 95% CI: -1.3 to -0.2; P = 0.012) compared with no reduction in Group 2 (from 2.3 ± 1.1 ng/mL at baseline to 1.9 ± 0.9 ng/mL at 3-month follow-up; 95% CI: -1 to -0.2; P = 0.09). LIMITATIONS, REASON FOR CAUTION: The key limitations of the trial were the low accuracy of AFC in estimating the ovarian reserve in ovaries with endometriomas, the limited study size and the relatively short follow-up, which do not allow us to draw definitive conclusions. WIDER IMPLICATIONS OF THE FINDINGS: The present study suggests that CO2 technology may treat endometrioma with minimal damage to the adjacent healthy ovarian tissue; however, this study should be considered as a preliminary clinical trial, intended to stimulate future larger trials to address this clinically relevant issue. STUDY FUNDING/COMPETING INTEREST(S): None. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov NCT03227640. TRIAL REGISTRATION DATE: 9 July 2017. DATE OF FIRST PATIENT’S ENROLLMENT: 24 July 2017.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Candiani M, Ottolina J, Posadzka E, et al. Assessment of ovarian reserve after cystectomy versus 'one-step' laser vaporization in the treatment of ovarian endometrioma: a small randomized clinical trial. Hum Reprod. 2018. PMID: 30299482. doi:10.1093/humrep/dey305

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。